nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
|
Meunier, Mathieu |
|
2014 |
20 |
9 |
p. 1451-1454 4 p. |
artikel |
2 |
Bendamustine Combined with Donor Lymphocytes Infusion in Hodgkin's Lymphoma Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
|
Sala, Elisa |
|
2014 |
20 |
9 |
p. 1444-1447 4 p. |
artikel |
3 |
CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation
|
Stasia, Alessandra |
|
2014 |
20 |
9 |
p. 1440-1443 4 p. |
artikel |
4 |
Clostridium Difficile Colonization and Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
|
Bruminhent, Jackrapong |
|
2014 |
20 |
9 |
p. 1329-1334 6 p. |
artikel |
5 |
Early versus Late Preemptive Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Acute Myeloid Leukemia
|
Chen, George L. |
|
2014 |
20 |
9 |
p. 1369-1374 6 p. |
artikel |
6 |
Editorial Board
|
|
|
2014 |
20 |
9 |
p. A4- 1 p. |
artikel |
7 |
Engraftment Syndrome after Allogeneic Hematopoietic Cell Transplantation Predicts Poor Outcomes
|
Chang, Lawrence |
|
2014 |
20 |
9 |
p. 1407-1417 11 p. |
artikel |
8 |
Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
|
Gatza, Erin |
|
2014 |
20 |
9 |
p. 1426-1434 9 p. |
artikel |
9 |
Everolimus in Combination with Mycophenolate Mofetil as Pre- and Post-Transplantation Immunosuppression after Nonmyeloablative Hematopoietic Stem Cell Transplantation in Canine Littermates
|
Machka, Christoph |
|
2014 |
20 |
9 |
p. 1301-1306 6 p. |
artikel |
10 |
Financial Burden in Recipients of Allogeneic Hematopoietic Cell Transplantation
|
Khera, Nandita |
|
2014 |
20 |
9 |
p. 1375-1381 7 p. |
artikel |
11 |
Graft-versus-Host Disease Causes Broad Suppression of Hematopoietic Primitive Cells and Blocks Megakaryocyte Differentiation in a Murine Model
|
Lin, Yan |
|
2014 |
20 |
9 |
p. 1290-1300 11 p. |
artikel |
12 |
Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival
|
Logan, Aaron C. |
|
2014 |
20 |
9 |
p. 1307-1313 7 p. |
artikel |
13 |
Impact of Age on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease
|
El-Jawahri, Areej |
|
2014 |
20 |
9 |
p. 1341-1348 8 p. |
artikel |
14 |
Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
|
Gupta, Vikas |
|
2014 |
20 |
9 |
p. 1274-1281 8 p. |
artikel |
15 |
Long-Term Outcome of Fludarabine-Based Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Debilitating Paroxysmal Nocturnal Hemoglobinuria
|
Pantin, Jeremy |
|
2014 |
20 |
9 |
p. 1435-1439 5 p. |
artikel |
16 |
Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
|
Törlén, Johan |
|
2014 |
20 |
9 |
p. 1418-1425 8 p. |
artikel |
17 |
Masthead (Purpose and Scope)
|
|
|
2014 |
20 |
9 |
p. A2- 1 p. |
artikel |
18 |
Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation
|
Martínez-Bravo, María José |
|
2014 |
20 |
9 |
p. 1356-1362 7 p. |
artikel |
19 |
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin
|
Capelli, Debora |
|
2014 |
20 |
9 |
p. 1399-1406 8 p. |
artikel |
20 |
Next Generation MRD
|
Hourigan, Christopher S. |
|
2014 |
20 |
9 |
p. 1259-1260 2 p. |
artikel |
21 |
[No title]
|
|
|
2014 |
20 |
9 |
p. 1459- 1 p. |
artikel |
22 |
Novel Strategy for Successful Long-Term Hematopoietic Recovery after Transplanting a Limited Number of Hematopoietic Stem/Progenitor Cells
|
Lee, Hakmo |
|
2014 |
20 |
9 |
p. 1282-1289 8 p. |
artikel |
23 |
Officers, Directors, and Board Committee Chairs
|
|
|
2014 |
20 |
9 |
p. A6- 1 p. |
artikel |
24 |
Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to Myelodysplastic Syndrome or Leukemia from Severe Aplastic Anemia: A Report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
|
Hussein, Ayad Ahmed |
|
2014 |
20 |
9 |
p. 1448-1450 3 p. |
artikel |
25 |
Outcomes of Human Leukocyte Antigen–Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Conditioning Regimens
|
Sobecks, Ronald M. |
|
2014 |
20 |
9 |
p. 1390-1398 9 p. |
artikel |
26 |
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|
Duong, Hien K. |
|
2014 |
20 |
9 |
p. 1262-1273 12 p. |
artikel |
27 |
Predictive Value of Circulating Angiopoietin-2 for Endothelial Damage–Related Complications in Allogeneic Hematopoietic Stem Cell Transplantation
|
Ueda, Norihiro |
|
2014 |
20 |
9 |
p. 1335-1340 6 p. |
artikel |
28 |
Pretransplantation Therapy with Hypomethylating Agents in Patients with Myelodysplastic Syndromes Receiving Reduced-Intensity Conditioning Regimens
|
Della Porta, Matteo Giovanni |
|
2014 |
20 |
9 |
p. 1260-1261 2 p. |
artikel |
29 |
Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
|
Mawad, Raya |
|
2014 |
20 |
9 |
p. 1363-1368 6 p. |
artikel |
30 |
Superior Survival of Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Compared with Chemotherapy Alone Used as Post-Remission Therapy in Adults with Standard-Risk Acute Lymphoblastic Leukemia in First Complete Remission
|
Yan, Chen-Hua |
|
2014 |
20 |
9 |
p. 1314-1321 8 p. |
artikel |
31 |
Table of Contents
|
|
|
2014 |
20 |
9 |
p. A11-A15 nvt p. |
artikel |
32 |
The Emerging Role of Gemcitabine in Conditioning Regimens for Hematopoietic Stem Cell Transplantation
|
Wang, Emily |
|
2014 |
20 |
9 |
p. 1382-1389 8 p. |
artikel |
33 |
“To Combine or Not to Combine:” Optimizing Risk Assessment before Allogeneic Hematopoietic Cell Transplantation
|
ElSawy, Mahmoud |
|
2014 |
20 |
9 |
p. 1455-1456 2 p. |
artikel |
34 |
Unexpected Outbreak of Epstein-Barr Virus Post-Transplantation Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation Conditioning with Thymoglobulin
|
Yáñez, Lucrecia |
|
2014 |
20 |
9 |
p. 1457-1458 2 p. |
artikel |
35 |
Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire
|
Damaj, Gandhi |
|
2014 |
20 |
9 |
p. 1349-1355 7 p. |
artikel |
36 |
Validation of the Disease Risk Index for Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after T Cell Depletion
|
Beauverd, Yan |
|
2014 |
20 |
9 |
p. 1322-1328 7 p. |
artikel |